🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
Prospective, double-blind, randomized assessment of the efficacy, safety an...
Status
Completed
Location
Research Site 1
Start Date
2017-03-29
Trial ID
NCT03027609
Unresectable metastatic colorectal cancer (mCRC) remains an incurable disea...
Status
Active Not Recruiting
Location
Centre Georges-François Leclerc
Start Date
2022-10-13
Trial ID
NCT05201352
Treatments Being Tested
The main purpose of this research study is to determine the maximum tolerab...
Status
Active Not Recruiting
Location
University of Rochester
Start Date
2020-11-23
Trial ID
NCT04477343
Treatments Being Tested
The main objective will be to test the safety of two intravenous infusions ...
Status
Completed
Location
Multiple Locations
Start Date
2003-07
Trial ID
NCT00066989
Treatments Being Tested
The purpose of this protocol is to evaluate the efficacy of tulisokibart in...
Status
Active Not Recruiting
Location
Digestive Health Specialists ( Site 0135)
Start Date
2023-10-25
Trial ID
NCT06052059
Treatments Being Tested
As of 30/03/2020, 715600 people have been infected with COVID-19 worldwide ...
Status
Completed
Location
CHU Sud Amiens
Start Date
2020-04-11
Trial ID
NCT04350580
Treatments Being Tested
This 2-arm, multi-center, open-label, parallel-group phase II trial will as...
Status
Completed
Location
Managadze National Center of Urology
Start Date
2021-01-20
Trial ID
NCT04733040
Treatments Being Tested
A randomized, open-label, prospective, multicenter study designed to invest...
Status
Recruiting
Location
Phoenix Children's Hospital
Start Date
2019-02-28
Trial ID
NCT03684018
Treatments Being Tested
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058